0001209191-20-036295.txt : 20200612 0001209191-20-036295.hdr.sgml : 20200612 20200612163700 ACCESSION NUMBER: 0001209191-20-036295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200611 FILED AS OF DATE: 20200612 DATE AS OF CHANGE: 20200612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deese Willie A CENTRAL INDEX KEY: 0001328766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38096 FILM NUMBER: 20960665 MAIL ADDRESS: STREET 1: DENTSPLY SIRONA INC STREET 2: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: G1 Therapeutics, Inc. CENTRAL INDEX KEY: 0001560241 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263648180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 PARK OFFICES DRIVE STREET 2: SUITE 200 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-213-9835 MAIL ADDRESS: STREET 1: 700 PARK OFFICES DRIVE STREET 2: SUITE 200 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: G-Zero Therapeutics, Inc. DATE OF NAME CHANGE: 20121012 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-11 0 0001560241 G1 Therapeutics, Inc. GTHX 0001328766 Deese Willie A C/O G1 THERAPEUTICS, 700 PARK OFFICES DR SUITE 200 RESEARCH TRIANGLE PARK NC 27709 1 0 0 0 Stock Option (right to buy) 17.59 2020-06-11 4 A 0 20000 0.00 A 2030-06-11 Common Stock 20000 20000 D The shares underlying this option will vest in their entirety twelve months after June 11, 2020, subject to the Reporting Person's continued service as a director. /s/ James Stillman Hanson, attorney in fact 2020-06-12